XOMA

XOMA Royalty Corp · Healthcare

Insider Buying

$2.5M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

Jul 15, 2026

Hughes Owen

XOMA Royalty Corp (XOMA) has 29 SEC Form 4 filings (48 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 15, 2026.

Inside the rolling window, 1 insider at XOMA Royalty Corp reported 1 open-market purchase totaling $2.5M and no open-market sales. The most recent open-market filing is a purchase of 100,000 shares by Chief Executive Officer Hughes Owen, dated Dec 4, 2025, worth $2.5M.

  • Industry:Biotechnology
  • CEO:Owen Hughes Jr.
  • Employees:14
  • HQ:EmeryVille, CA, US
  • IPO:1986-06-06
Source
Hughes OwenFirst filing
Purchase$2.5MDec 8SEC ↗
Showing 1–1 of 1
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does XOMA have?

XOMA Royalty Corp (XOMA) has 29 SEC Form 4 filings (48 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 15, 2026.

When was the most recent SEC Form 4 filing for XOMA?

The most recent Form 4 filing for XOMA on Tracefour is dated Jul 15, 2026.

What is the total insider buy and sell value at XOMA in the current window?

Inside the rolling window, insiders at XOMA bought $2.5M and sold $0 based on SEC Form 4 filings.

Can I get alerts for XOMA insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at XOMA Royalty Corp (XOMA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

XOMA Royalty Corp is in the Healthcare sector.